Start Life Science Seite 3

Life Science

Impact Life Sciences Deep Dive (c) VC Magazin
Life Science

Impact Life Sciences Deep Dive: Local excellence, national bottlenecks, global opportunities

Redaktion -
0
Dr Jonathan Talbot (Mosanna Therapeutics, Melodia Therapeutics), Dr Stefano Portolano (Azafaros), Prof. Dr med. Wieland Sommer (Jacobian)(c) Melodia Therapeutics/Jacobian/Azafaros
Life Science

Finalists for the 2026 Strüngmann Award announced

Redaktion -
0
Jannis Grube, PwC Germany und Andreas du Plessis, Simplants
Life Science

‘Technology is only one part of the challenge’

Janine Heidenfelder -
0
Sella Brosh, NVision
Life Science

Pioneering quantum health

Redaktion -
0
Vorstellung des Jahresreport „Biotech in Bavaria - Where champions grow“ in Martinsried: Dr. Julian Dieler (StMWi), Verena Vitz (EY), Dr. Jonas Helma-Smets (Tubulis) und Prof. Ralf Huss (BioM) (v.l.n.r.). © BioM
Life Science

Bayerns Biotech-Branche erreicht Rekord bei Finanzierungen

Redaktion -
0
Dr Leila Jaafar-Thiel, Nuclidium
Interviews

‘Copper theranostics bring diagnosis and treatment together in a highly effective way’

Redaktion -
0
The era of outsourcing in biotech
Life Science

The era of outsourcing in biotech

Redaktion -
0
Klaus Ort, EY-Parthenon, präsentiert die Ergebnisse des „German Biotechnology Report 2026“ auf dem Biotech Finanzgipfel, organisiert von Bio Deutschland (c) VC Magazin
Life Science

Biotech-Finanzierungen sinken, Wachstumsphase bleibt Schwachstelle

Redaktion -
0
Special "Impact Life Sciences" 02/26
Life Science

Now online: Special „Impact Life Sciences 02/26“!

Redaktion -
0
Nidra™ and TOMAC Therapy for Restless Legs Syndrome (c) Noctrix Health
Deals

Angelini Ventures: Noctrix Health acquired by ResMed

Redaktion -
0
Leila Jaafar, CEO and Co-Founder Nuclidium (c) Nuclidium
Deals

Nuclidium: CHF 26 million Series B extension round

Redaktion -
0
Mathias Klozenbücher (FCF), Dr. Peggy Jungke (nukliD®), Fabrizio Calisti (Angelini Ventures), Odile Jaume (ICPO Foundation), Prof. Dr Richard Baum (ICPO Foundation), Prof. Dr Klaus Kopka (Helmholtz Zentrum Dresden-Rossendorf) & Thomas Horn (Saxony Trade & Invest Corp. (WFS))
Life Science

Germany is emerging as a hub for nuclear medicine

Redaktion -
0
The team at Rivermark Medical (c) Rivermark Medical
Deals

Series D financing round in Rivermark Medical

Redaktion -
0
Dr. Matthias Schäfer; Silvia Scherer; Topadur Pharma AG
Life Science

Microcirculation is key

Heike Autschbach -
0
Dr. Holger Bengs, BCNP Consultants
Interviews

The ultimate funding hack? A real value proposition and strong industry partners

Redaktion VentureCapital Magazin -
0
1234...11Seite 3 von 11

Branchenevents

Kalender anzeigen
© Newspaper WordPress Theme by TagDiv